Stuart A Arbuckle Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 week, 1 day ago
Stuart A Arbuckle has an estimated net worth of at least $51.4 million*, as of Dec. 18, 2024. They own 49,691 shares of VRTX stock. They have sold 82,298 shares of VRTX stock since 2021, for an estimated $28.1 million.
Stuart A Arbuckle $VRTX SEC Form 4 Insider Trading
Stuart A Arbuckle has filed a total of 46 insider trades in $VRTX since 2021. Their most recent trade was a sale of 69 shares, made on May 15, 2024. Their largest trade was a sale of 8,603 shares, made on Dec 13, 2023. We estimate that they now own 49,691 shares of $VRTX, worth an estimated $23.3 million.
Insider Trading at $VRTX
There have been a total of 474 insider trades reported at $VRTX since 2021, with 25,000 shares purchased and 808,928 shares sold. The most active insider traders in $VRTX stock have been David Altshuler, Bastiano Sanna, and Ourania Tatsis. The most recent trade was a sale of 15 shares reported by DAVID ALTSHULER (EVP, Chief Scientific Officer), made on Nov 15, 2024.
History of Insider Stock Trades by Stuart A Arbuckle
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
VRTX | Sale | 69 | May 15, 2024 | May 17, 2024, 4:24 p.m. |
VRTX | Sale | 5,034 | Feb 26, 2024 | Feb. 27, 2024, 5:37 p.m. |
VRTX | Sale | 3,603 | Feb 21, 2024 | Feb. 23, 2024, 5:12 p.m. |
VRTX | Sale | 4,804 | Feb 20, 2024 | Feb. 21, 2024, 5:19 p.m. |
VRTX | Sale | 4,295 | Feb 12, 2024 | Feb. 13, 2024, 5:51 p.m. |
VRTX | Sale | 8,603 | Dec 13, 2023 | Dec. 15, 2023, 5:20 p.m. |
VRTX | Sale | 8,603 | Jun 15, 2023 | June 20, 2023, 4:07 p.m. |
VRTX | Sale | 82 | May 30, 2023 | June 1, 2023, 4:16 p.m. |
VRTX | Sale | 400 | Feb 27, 2023 | Feb. 28, 2023, 5:47 p.m. |
VRTX | Sale | 800 | Feb 27, 2023 | Feb. 28, 2023, 5:47 p.m. |
VRTX | Sale | 3,834 | Feb 27, 2023 | Feb. 28, 2023, 5:47 p.m. |
VRTX | Sale | 300 | Feb 22, 2023 | Feb. 24, 2023, 5:06 p.m. |
VRTX | Sale | 200 | Feb 22, 2023 | Feb. 24, 2023, 5:06 p.m. |
VRTX | Sale | 394 | Feb 22, 2023 | Feb. 24, 2023, 5:06 p.m. |
VRTX | Sale | 1,378 | Feb 22, 2023 | Feb. 24, 2023, 5:06 p.m. |
VRTX | Sale | 129 | Feb 22, 2023 | Feb. 24, 2023, 5:06 p.m. |
VRTX | Sale | 560 | Feb 14, 2023 | Feb. 16, 2023, 5:14 p.m. |
VRTX | Sale | 400 | Feb 14, 2023 | Feb. 16, 2023, 5:14 p.m. |
VRTX | Sale | 1,734 | Feb 14, 2023 | Feb. 16, 2023, 5:14 p.m. |
VRTX | Sale | 2,003 | Feb 14, 2023 | Feb. 16, 2023, 5:14 p.m. |
VRTX | Sale | 800 | Feb 14, 2023 | Feb. 16, 2023, 5:14 p.m. |
VRTX | Sale | 901 | Feb 14, 2023 | Feb. 16, 2023, 5:14 p.m. |
VRTX | Sale | 835 | Feb 13, 2023 | Feb. 14, 2023, 5:53 p.m. |
VRTX | Sale | 245 | Feb 13, 2023 | Feb. 14, 2023, 5:53 p.m. |
VRTX | Sale | 2,028 | Feb 13, 2023 | Feb. 14, 2023, 5:53 p.m. |
VRTX | Sale | 1,779 | Feb 13, 2023 | Feb. 14, 2023, 5:53 p.m. |
VRTX | Sale | 1,254 | Aug 15, 2022 | Aug. 17, 2022, 5:39 p.m. |
VRTX | Sale | 6,948 | Aug 15, 2022 | Aug. 17, 2022, 5:39 p.m. |
VRTX | Sale | 6,990 | Aug 15, 2022 | Aug. 17, 2022, 5:39 p.m. |
VRTX | Sale | 2,339 | Aug 15, 2022 | Aug. 17, 2022, 5:39 p.m. |
VRTX | Sale | 400 | Aug 15, 2022 | Aug. 17, 2022, 5:39 p.m. |
VRTX | Sale | 4,242 | Aug 15, 2022 | Aug. 17, 2022, 5:39 p.m. |
VRTX | Sale | 9 | Aug 10, 2022 | Aug. 12, 2022, 4:05 p.m. |
VRTX | Sale | 171 | Aug 10, 2022 | Aug. 12, 2022, 4:05 p.m. |
VRTX | Sale | 900 | Aug 09, 2022 | Aug. 10, 2022, 4:06 p.m. |
VRTX | Sale | 4,790 | Aug 09, 2022 | Aug. 10, 2022, 4:06 p.m. |
VRTX | Sale | 11 | May 16, 2022 | May 17, 2022, 8 p.m. |
VRTX | Sale | 40 | May 16, 2022 | May 17, 2022, 8 p.m. |
VRTX | Sale | 10 | May 16, 2022 | May 17, 2022, 8 p.m. |
VRTX | Sale | 10 | May 16, 2022 | May 17, 2022, 8 p.m. |
VRTX | Sale | 32 | May 16, 2022 | May 17, 2022, 8 p.m. |
VRTX | Sale | 20 | May 16, 2022 | May 17, 2022, 8 p.m. |
VRTX | Sale | 10 | May 16, 2022 | May 17, 2022, 8 p.m. |
VRTX | Sale | 306 | May 02, 2022 | May 4, 2022, 5:21 p.m. |
VRTX | Sale | 1 | Nov 15, 2021 | Nov. 16, 2021, 5:05 p.m. |
VRTX | Sale | 2 | Nov 15, 2021 | Nov. 16, 2021, 5:05 p.m. |
$VRTX Executives and Stock Owners with Insider Trades
-
David Altshuler, EVP, Global Research and CSO
-
Bastiano Sanna, EVP, Cell & Genetic Therapies
-
Ourania Tatsis, EVP, Chief Reg. & Quality Off.
-
Stuart A Arbuckle, EVP, COO
-
Charles F Jr Wagner, EVP & Chief Financial Officer
-
Jeffrey M Leiden, Executive Chairman
-
Joy Liu, SVP, General Counsel
-
Reshma Kewalramani, CEO & President
-
Carmen Bozic, EVP and CMO
-
Kristen Ambrose, SVP & Chief Accounting Officer
-
Amit Sachdev, EVP Chief Patient & Ext Af Off
-
Edward Morrow Iii Atkinson, EVP, Chief Technical Ops. Off.
-
Amit Sachdev, EVP, Chief Patient Officer
-
Jonathan Biller, EVP and Chief Legal Officer
-
David Altshuler, EVP, Chief Scientific Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.